Recent

% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • swalchie swalchie Mar 20, 2013 6:32 AM Flag

    Another hedge fund hit piece out by Bloomberg this am

    How low do they want this before launch? I added yesterday looks like I should have waited!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Wow looks like those shares I bought yesterday were not a mistake. Been a while since I have had a green block of Arna trading shares! Lol

    • I added on the last "one last Bear Raid" a month ago. Yes this is still a trading stock. if something positive doesn't happen after this "One last Bear Raid" Big Investors are going to start leaving. You can only take so much BS.

    • This has all been telegraphed and expected... the hits on all levels. Pretty effective recently too,
      if I may say. The ruthlessness is quite stunning. The passive aggressive attacks like the Bloomberg
      stuff are the most effective ways to tell half-truths and not so accurate "facts", that's for sure! Scary!

      Sentiment: Strong Buy

    • Another one-sided misinform article by Ryan Flinn. This article is #$%$. He is comparing the "Apples to Oranges"! He wrote: "New prescriptions of Vivus Inc.’s (VVUS) Qsymia, on the market since September, have declined 22 percent since peaking on Feb. 8, a drop that analysts say may be caused by high patient costs. That’s led shares of San Diego-based Arena Pharmaceuticals Inc. (ARNA) won’t climb when its drug, called Belviq, goes on sale in the U.S. later this year. " of San Diego-based Arena Pharmaceuticals Inc. (ARNA) won’t climb when its drug, called Belviq, goes on sale in the U.S. later this year. "
      1. He can not compare Qsymia, a two generic cambo, to a new innovative drug Belviq.
      2. VVUS launch was a failure because they try to do it alone with a small inexperience team of sale & marketing team.
      3. ARNA Launch will be a success because they have Eisai doing it with a large experience sale and
      marketing team.
      Therefore, shares of San Diego-based Arena Pharmaceuticals Inc. (ARNA) will climb when its drug, called Belviq, goes on sale in the U.S. EARLY this year. Another intention mistake, he said later this year.
      4. The price declined because of MM manipulation while waiting for the DEA final Schedule not because investors are betting that shares of ARNA won’t climb when it launches Belviq!!!

      This guy should be reported to the SEC. Defenetly he is a basher working for the hedge fund managers who shorted ARNA and want cover.

      Sentiment: Hold

      • 1 Reply to srt121
      • If Ryan Flinn writes another piece like that one, I am emailing his English teacher and seeing to it that he serves a detention. I think he's trying to impress a girl in an Econ. class that he knows how to write. High school students do more research. Sadly, some "investors" will sell on his news. Fine by me. That beeping you hear is the sound of the truck backing up.

    • they forgot about the naked shorting. When the hel is the dea gonna finalize. damn

      Sentiment: Strong Buy

 
ARNA
4.18-0.02(-0.48%)3:09 PMEDT